By Editor , 31 October 2026
RVL Pharmaceuticals Posts Double-Digit Q3 Revenue Growth on Upneeq

Bridgewater, N.J. – October 30, 2026 -- RVL Pharmaceuticals reported double-digit year-over-year revenue growth in the third quarter, driven by rising consumer demand for its prescription eye drop Upneeq, a national celebrity campaign and a widened product line.